Showing results (641-650 of 651) with videos related to
Sort By:
Pageof 66
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2026
Respiratory Syncytial Virus After CAR T-cell therapy: Risk Factors and Outcomes in a Multicenter Retrospective CohortMaria Isabel Sotelo-Alva, Ofrat Beyar-Katz, Judy Yan, et al.Haematologica|June 20, 2024
Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphomaOhad Benjamini, Shalev Fried, Roni Shouval, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 12, 2023
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of CardiologyJavier Escaned, Colin Berry, Bernard De Bruyne, et al.Transplantation and Cellular Therapy|April 6, 2026
Outcomes of Salvage Therapy After Early-Line CD19 CAR-T Failure in Large B-Cell LymphomaSilvia Escribano Serrat, Andrew Ip, Jaime Sanz, et al.Journal of Cellular and Molecular Medicine|October 22, 2025
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic LeukaemiaOfrat Beyar-Katz, Ohad Benjamini, Julio Delgado, et al.Transplantation and Cellular Therapy|March 1, 2026
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell LymphomaMarina Gomez-Llobell, Roni Shouval, Samantha Brown, et al.Blood Advances|October 22, 2025
Prognostic Value of Inflammation-Based Scores in R/R LBCL Patients Treated with CD3xCD20 Bispecific T-Cell EngagersGiulia Magno, Kai Rejeski, Giulia Rappa, et al.Circulation|September 23, 2024
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF TrialGregg W Stone, JoAnn Lindenfeld, Josep Rodés-Cabau, et al.Blood|April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell TherapyKai Rejeski, Jaime Sanz, Teng Fei, et al.Blood|January 5, 2026
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell LymphomaDanny Luan, Ori Ben Valid, Ofrat Beyar-Katz, et al.Pageof 66